At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,868 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Follow up of Learning Early About Peanut Allergy (LEAP) Participants and Their Families: LEAP Trio (ITN070AD)
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Jun 6, 2018·Updated Mar 29, 2024
In Brief
An observational study for Peanut Allergy. Completed, enrolled 1,868 participants across 1 site.
Detailed Summary
This prospective, cross-sectional study was designed to improve understanding of how early-life introduction of peanuts may promote the maintenance of tolerance in adolescence and will serve as an additional safety evaluation of the original nutritional intervention.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeanut Allergy
CountriesUnited Kingdom
CollaboratorsImmune Tolerance Network (ITN), PPD Development, LP
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 2018
Enrollment StartJul 2018
Primary CompletionAug 2022
TodayJul 2026
First PostedJun 6, 2018
Enrollment StartJul 5, 2018
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 8.1 years ago